Send to

Choose Destination
See comment in PubMed Commons below
Expert Opin Med Diagn. 2011 Nov;5(6):527-38. doi: 10.1517/17530059.2011.617365. Epub 2011 Oct 18.

Amyloid imaging for Alzheimer's disease.

Author information

Stanford University School of Medicine, Stanford Center for Memory Disorders , Department of Neurology and Neurological Sciences , 300 Pasteur Drive, Room A343, MC5235, Stanford, W CA 94305-5235 , USA +1 650 723 2078 ; +1 650 723 7434 ;



Biomarkers for Alzheimer's disease (AD) may facilitate early and accurate diagnosis and offer a way to track the effectiveness of new therapies. Amyloid imaging offers an unrivaled ability to visualize the presence and anatomical distribution of fibrillar beta-amyloid (Aβ) pathology non-invasively in living humans. New diagnostic criteria for AD incorporate the use of such biomarkers as amyloid imaging, highlighting the importance of this technology going forward.


Here, the author reviews individual amyloid tracers, including the (11)C-labeled tracer Pittsburgh compound B and the (18)F-labeled tracers nearing FDA approval. While these tracers are reliable at detecting fibrillar Aβ pathology, there is a weaker connection with true AD pathology, reflecting the complex relationship between Aβ and AD. The author discusses apolipoprotein E genotyping and spinal fluid Aβ levels in relation to amyloid imaging, and considers the possible uses of amyloid imaging as a diagnostic instrument in the clinic, or as a clinical trials tool for selecting patients or monitoring outcomes. Selected literature retrieved by Medline searches for 'amyloid imaging' and related terms from 2001 to present is discussed.


Amyloid imaging accurately portrays the presence of fibrillar Aβ pathology in the brain. However, fundamental questions about the role of Aβ in AD must be answered before the full potential of amyloid imaging can be realized.

PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center